all report title image

SMOKING CESSATION AND NICOTINE DE-ADDICTION PRODUCTS MARKET ANALYSIS

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration (Oral, Transdermal, Nasal , Sublingual), By Product (Nicotine Replacement Therapy, Nicotine Spray, Nicotine Inhalers, Nicotine Gum, Nicotine Transdermal Patches, Nicotine Sublingual Tablets, Nicotine Lozenges, Drug Therapy, Varenicline, Zyban, Nicorette Buccal, E-cigarettes/E-liquid), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI134
  • Pages :358
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Smoking Cessation and Nicotine De-addiction Products Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing consumption of tobacco products

Rising tobacco consumption worldwide has become a major public health issue. According to the WHO, over 1.3 billion people use tobacco globally with over 8 million deaths attributed to direct tobacco use annually. The health consequences of tobacco use such as cancers, cardiovascular, and respiratory diseases have seen steady rise. This is prompting many smokers to think about quitting smoking. At the same time, governments and health agencies across nations are promoting effective smoking cessation programs to help current smokers quit tobacco. All of these factors are directly fueling the growth of the global smoking cessation and nicotine de-addiction products industry. As per recent data published by CDC, nearly 70% of current U.S. adult smokers said they want to quit completely in 2020, up from 50-60% over the last decade. This shows that more smokers are willing to adopt de-addiction methods like nicotine replacement therapy and e-cigarettes. Major players in the industry are tapping into this opportunity by continuously expanding their product portfolios to suit diverse needs of smokers. 

Key Players Insights
  • GlaxoSmithKline plc (GSK)
  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis International AG
  • Imperial Brands plc
  • British American Tobacco plc (BAT)
  • Cipla Inc.
  • McNeil AB
  • NJOY, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Perrigo Company plc
  • Fertin Pharma
  • Philip Morris International Inc.
  • Alkalon A/S
  • Japan Tobacco Inc.
  • Nicotek, LLC
  • 22nd Century Group Inc.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.